## Ethics of placebo-controlled trials in depression Some believe that introducing a placebo control into an antidepressant drug trial means that ill patients are being unnecessarily deprived of treatment. As a result, many clinicians and ethical committees are opposed to the use of such trial met
The Ethics of Placebo-controlled Trials: A Comparison of Inert and Active Placebo Controls
β Scribed by Sarah J. L. Edward; Andrew J. Stevens; David A. Braunholtz; Richard J. Lilford; Teresa Swift
- Publisher
- Springer
- Year
- 2005
- Tongue
- English
- Weight
- 95 KB
- Volume
- 29
- Category
- Article
- ISSN
- 0364-2313
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
In placebo-controlled antidepressant trials, there are concerns that the double blind may be breached, which may bias results. Some trials have therefore used placebos containing active substances in order to mimic the side effects of antidepressants. This study set out to examine the impact of 'unb
## Abstract The purpose of this article is to clarify the decision points that are important to consider when evaluating the ethics of a placeboβcontrolled trial. The ethical requirements for research involving human subjects are reviewed, and the rationale for and potential problems with concomita
## Methods Myopathy occurs in association with human immunodeficiency virus type 1 (HIV-1) infection, 2,8,17,19 and AIDS Clinical Trials Group (ACTG) Protocol 016 was designed to explore the safety and efficacy of ZDV as toxicity of the antiretroviral agent zidovudine (ZDV, AZT). 3,6,9,15 Retrospe
Sixty-two patients with moderately severe anxiety symptoms were treated in a double bline 3-week trial with either oxprenolol, diazepam or placebo. The Hamilton Anxiety Scale and a Target symptom improvement score were the main measures of change used. All treatment groups significantly improved in